Navigation Links
China Biologic Schedules Conference Call to Discuss Third Quarter 2009 Financial Results
Date:11/13/2009

TAI'AN CITY, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in China, today announced that the Company will host a conference call at 8:00 a.m. ET on Monday, November 16, 2009, to discuss the 2009 third quarter financial results ended on September 30, 2009.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-356-3093. International callers should dial +1-617-597-5381. The pass code for the call is 91606809.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Monday, November 16, 2009 at 10:00 a.m. ET. To access the replay, dial 888-286-8010, international callers should dial +1-617-801-6888. The conference pass code is 78299906.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Chongqing Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. For more information please visit the Company's website http://www.chinabiologic.com

    For more information, please contact:

    Company Contact:
     Mr. Y. Tristan Kuo
     Chief Financial Officer
     China Biologic Products, Inc.
     Tel:   +86-538-6202206
     Email: IR@chinabiologic.com
     Web:   http://www.chinabiologic.com

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Athan Dounis, Account Manager
     Tel:   +1-646-213-1916
     Email: athan.dounis@ccgir.com

     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:   http://www.ccgasiair.com

SOURCE China Biologic Products, Inc.


'/>"/>
SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates
2. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2009 Results
3. China Medicine Announces Conference Call to Discuss Third Quarter 2009 Results
4. Monsanto Opens First Biotechnology Research Center in China
5. Chinas Research Output More Than Doubled Since 2004, Thomson Reuters Study Reveals
6. China-Biotics, Inc. Appoints New Vice President
7. Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
8. China Biologic Named to Forbes Magazines Fifth Annual List of Asias 200 Best Under a Billion
9. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China
10. China Medical Technologies Announces the SFDA Approval for its SPR System
11. China Integrated Energy, Inc. Announces Preliminary Third Quarter Financial Results and Increases Full Year Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... Cutting Edge Spine ... highly differentiated spinal implant technologies, announced today the appointment of Luke Maher as ... device industry experience to directing Cutting Edge Spine’s national sales force, including 12+ ...
(Date:8/22/2017)... ... August 22, 2017 , ... KBioBox is ... KBioBox technology, the extended GUIDE-Seq ananlysis. KBioBox has adapted their core technology and ... provide scientists with easy to understand reports, extended indel analysis, and translocation analysis. ...
(Date:8/21/2017)... ... 2017 , ... MacArthur Sotheby’s International Realty, a luxury real ... the first Delos Wellness Signature™ residence in Hawaii is on the market for ... listing agent Kelly Allen, R(S) of Carvill Sotheby’s International Realty located on Oahu, ...
(Date:8/21/2017)... Baltimore, Maryland (PRWEB) , ... August 21, 2017 ... ... has partnered with a leading Chinese bio security firm, to bring its proprietary ... As part of the relationship, the Chinese firm has purchased an undisclosed ...
Breaking Biology Technology:
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at http://www.sec.gov . ...
(Date:4/13/2017)... -- According to a new market research report "Consumer IAM ... and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global ... grow from USD 14.30 Billion in 2017 to USD 31.75 Billion by ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Biology News(10 mins):